- Ataxia-telangiectasia: A review of movement disorders, clinical features and genotype correlations - Addendum.
- Ataxia-telangiectasia: A review of movement disorders, clinical features, and genotype correlations.
- Ataxia-telangiectasia: Immunodeficiency and survival.
- Ataxia-telangiectasia: recommendations for multidisciplinary treatment.
- Ataxia-telangiectasia.
- ATM and the molecular pathogenesis of ataxia telangiectasia.
- Atm reactivation reverses ataxia telangiectasia phenotypes in vivo.
- ATM splicing variants as biomarkers for low dose dexamethasone treatment of A-T.
- Audiological findings in children with ataxia-telangiectasia (A-T) syndrome.
- B-cell subsets imbalance and reduced expression of CD40 in ataxia-telangiectasia patients.
- Brain edema with clasmatodendrosis complicating ataxia telangiectasia.
- Cerebral abnormalities in adults with ataxia-telangiectasia.
- Childhood colon cancer in a patient with ataxia telangiectasia.
- Class switch recombination process in ataxia telangiectasia patients with elevated serum levels of IgM.
- Cognitive phenotype in ataxia-telangiectasia.
- Comparison of major lymphocyte subpopulations and recent thymic emigrants in patients with ataxia telangiectasia and age-matched healthy groups.
- Consequences of the delayed diagnosis of ataxia-telangiectasia.
- Corynebacterium propinquum bronchopneumonia in a child with ataxia telangiectasia.
- Cough ability measurements and recurrent respiratory symptoms in individuals with Ataxia Telangiectasia.
- Dexamethasone improves redox state in ataxia telangiectasia cells by promoting an NRF2-mediated antioxidant response.